SLC7A11 and breast carcinoma: Metformin down-regulates SLC7A11 expression by inhibiting UFMylation modification of SLC7A11, promoting ferroptosis in TNBC cancer cells, reducing breast cancer volume in vivo, and achieving better results when used in combination with sulfasalazine (110).